Novartis prostate cancer treatment sees positive Phase III results
March 23, 2021Manufacturing and Production Novartis, oncology
Novartis has today announced positive results from its Phase III VISION study with 177Lu-PSMA-617, seeing significant improvements in overall survival …
eTheRNA awarded €6.9 million TIGER Grant by European Commission
March 22, 2021Sales and Marketing Cancer, EU
eTheRNA immunotherapies, a clinical-stage company, has been awarded a grant of €6.9 million by the European Commission to develop a …
Daiichi Sankyo begins trial for mRNA COVID-19 vaccine in Japan
March 22, 2021Sales and Marketing COVID-19, Vaccine
Daiichi Sankyo, a global pharmaceutical company that provides services in 20 countries worldwide, has announced the first vaccinations as part …
FDA approves Kiniksa’s recurrent pericardis treatment ARCALYST
March 22, 2021Sales and Marketing FDA
The FDA have approved ARCALYST (rilonacept) for the treatment and risk reduction of recurrent pericardis in adults and children over …
Roche lung cancer treatment reports promising results in Phase III
March 22, 2021Sales and Marketing Roche, oncology
Roche’s IMpower010 study, evaluating Tecentriq (atezolizumab) compared with best supportive care, has shown significant improvement in disease-free survival (DFS) in …
AstraZeneca COVID-19 vaccine achieves safety and efficacy results in US
March 22, 2021Sales and Marketing
Results from the US trial of AstraZeneca’s COVID-19 vaccine (AZD1222) show it is 79% effective at stopping symptomatic COVID-19 disease …
Pharmafile.com’s top 10 news stories of the week
March 19, 2021Medical Communications COVID, COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news
In the last week, a number of new developments have made the news; for COVID-19, the Oxford-AstraZeneca vaccine has been …
RDIF & Stelis Biopharma to supply 200 million doses of the Sputnik V vaccine
March 19, 2021Medical Communications COVID-19, Russia, Vaccine
The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply …
NICE recommends new triple therapy for multiple myeloma patients
March 19, 2021Medical Communications NHS England, NICE, oncology
A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma, following a …
AstraZeneca COVID-19 vaccine deemed “safe and effective” by EMA
March 19, 2021Medical Communications AstraZeneca, COVID-19, EMA, Vaccine
AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 …
AstraZeneca & MSD ovarian cancer drug combination approved by NICE
March 19, 2021Medical Communications AstraZeneca, MSD, NICE, oncology
A new precision drug combination, olaparib with bevacizumab, will now be available on the Cancer Drugs Fund (CDF) for ovarian …
Antion launch new technology for cancer and tumour treatments
March 18, 2021Cancer, action, blood cancer, myeloma
Antion Biosciences has launched a new T-cell technology platform to help with the development of new curative therapies for diseases …
GSK starts Phase III study for severe asthma treatment
March 18, 2021GSK, asthma, phase III
GSK has announced today that the first patient has been dosed in part of their Phase III clinical trial investigating …
Florida woman gives birth to first-known baby born with COVID-19 antibodies
March 18, 2021COVID-19, Moderna, Vaccine
A woman from Florida has given birth to the first-known baby born with COVID-19 antibodies, according to findings recently published …
NICE recommends Daiichi Sankyo’s cholesterol-lowering treatments for NHS England use
March 18, 2021Daiichi Sankyo, NICE, cholesterol
NICE has recommended Daiichi Sankyo’s bempedoic acid and bempedoic acid/ezetimibe for treating primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed …
AstraZeneca leukaemia treatment recommended for NHS use
March 18, 2021AstraZeneca, NHS
AstraZeneca has announced today that its oral targeted cancer therapy, Calquence (acalabrutinib), has been recommended by NICE for routine use …
Pharmafile.com’s weekly COVID-19 news round-up
March 17, 2021Research and Development COVID-19, covid-19 roundup, news roundup
The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout …
Lilly’s ulcerative colitis treatment meets all key endpoints in Phase III trial
March 17, 2021Research and Development Eli Lilly, Phase III trial, lilly, mirikizumab, ulcerative colitis
Eli Lilly’s mirikizumab treatment for ulcerative colitis (UC) patients has met the primary endpoints and all key secondary endpoints in …
Axol Bioscience and CENSO Biotechnologies enter merger agreement
March 17, 2021Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience
Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …
PEP-Therapy and Institut Curie’s cancer drug trial approved in France
March 17, 2021Research and Development Cancer, France, Pep-therapy
PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
